NCT02184416 2026-02-27
ADONIS
Pfizer
Completed
Clinical Trials
18 trialsNCT01210482 2024-09-25
Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Pfizer
Completed
NCT00700258 2024-09-23
STAR-TOR
Pfizer
Completed
NCT01180049 2019-05-20
Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma
Pfizer
Phase 4 Completed
NCT01111825 2018-09-26
Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer
Puma Biotechnology, Inc.
Phase 1/2 Completed
NCT00838539 2018-09-18
Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors
Puma Biotechnology, Inc.
Phase 1 Completed
NCT01827267 2018-07-03
Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer
Puma Biotechnology, Inc.
Phase 2 Completed
NCT01646021 2018-01-19
Study of Ibrutinib (a Bruton's Tyrosine Kinase Inhibitor), Versus Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy
Janssen Research & Development, LLC
Phase 3 Completed
NCT00631371 2016-04-27
INTORACT
Pfizer
Phase 3 Completed
NCT01367457 2016-04-27
INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus
Pfizer
Completed
NCT00117598 2015-03-30
OPTIMAL
Pfizer
Phase 3 Completed
NCT00474786 2013-11-21
INTORSECT
Pfizer
Phase 3 Completed
NCT00106353 2013-02-08
Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors
Pfizer
Phase 1/2 Completed
NCT00065468 2012-10-25
ARCC
Pfizer
Phase 3 Completed
NCT00563147 2011-10-04
A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell Carcinoma
AVEO Pharmaceuticals, Inc.
Phase 1 Completed
NCT00062751 2011-04-15
Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 2 Completed
NCT00195299 2007-12-27
Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck
Wyeth is now a wholly owned subsidiary of Pfizer
Completed
NCT00235794 2007-12-27
An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients
Wyeth is now a wholly owned subsidiary of Pfizer
Phase NA Completed